CVE:PHM

Protech Home Medical Competitors

C$0.12
-0.01 (-4.17 %)
(As of 12/28/2018)
Add
Compare
Today's Range
C$0.11
Now: C$0.12
C$0.12
50-Day Range
C$0.12
MA: C$0.12
C$0.12
52-Week Range
C$0.08
Now: C$0.12
C$0.22
Volume1.53 million shs
Average Volume1.19 million shs
Market CapitalizationC$47.90 million
P/E Ratio57.50
Dividend YieldN/A
BetaN/A

Competitors

Protech Home Medical (CVE:PHM) Vs. VMD, TMD, HTL, PTQ, HSM, and ASG

Should you be buying PHM stock or one of its competitors? Companies in the industry of "medical devices" are considered alternatives and competitors to Protech Home Medical, including Viemed Healthcare (VMD), Titan Medical (TMD), Hamilton Thorne (HTL), Protech Home Medical (PTQ), Helius Medical Technologies (HSM), and Aurora Spine (ASG).

Viemed Healthcare (TSE:VMD) and Protech Home Medical (CVE:PHM) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, earnings, risk, analyst recommendations, institutional ownership and dividends.

Analyst Ratings

This is a summary of current ratings and target prices for Viemed Healthcare and Protech Home Medical, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Viemed Healthcare01002.00
Protech Home Medical0000N/A

Earnings and Valuation

This table compares Viemed Healthcare and Protech Home Medical's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Viemed HealthcareC$131.31 million3.53C$38.61 millionC$0.9812.02
Protech Home MedicalC$77.14 million0.62C$833,022.00C$0.0057.50

Viemed Healthcare has higher revenue and earnings than Protech Home Medical. Viemed Healthcare is trading at a lower price-to-earnings ratio than Protech Home Medical, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Viemed Healthcare and Protech Home Medical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Viemed HealthcareN/AN/AN/A
Protech Home MedicalN/AN/AN/A

Summary

Viemed Healthcare beats Protech Home Medical on 4 of the 5 factors compared between the two stocks.

Titan Medical (TSE:TMD) and Protech Home Medical (CVE:PHM) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.

Valuation & Earnings

This table compares Titan Medical and Protech Home Medical's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Titan MedicalC$20 million10.84C$-49,505,300.00C($0.45)-4.38
Protech Home MedicalC$77.14 million0.62C$833,022.00C$0.0057.50

Protech Home Medical has higher revenue and earnings than Titan Medical. Titan Medical is trading at a lower price-to-earnings ratio than Protech Home Medical, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings and price targets for Titan Medical and Protech Home Medical, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Titan Medical00103.00
Protech Home Medical0000N/A

Profitability

This table compares Titan Medical and Protech Home Medical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Titan MedicalN/AN/AN/A
Protech Home MedicalN/AN/AN/A

Summary

Protech Home Medical beats Titan Medical on 4 of the 6 factors compared between the two stocks.

Hamilton Thorne (CVE:HTL) and Protech Home Medical (CVE:PHM) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, profitability, risk, earnings, institutional ownership, analyst recommendations and dividends.

Analyst Recommendations

This is a summary of recent ratings and target prices for Hamilton Thorne and Protech Home Medical, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Hamilton Thorne00403.00
Protech Home Medical0000N/A

Hamilton Thorne presently has a consensus price target of C$1.87, indicating a potential upside of 7.47%. Given Hamilton Thorne's higher possible upside, analysts clearly believe Hamilton Thorne is more favorable than Protech Home Medical.

Profitability

This table compares Hamilton Thorne and Protech Home Medical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Hamilton ThorneN/AN/AN/A
Protech Home MedicalN/AN/AN/A

Earnings & Valuation

This table compares Hamilton Thorne and Protech Home Medical's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hamilton ThorneC$39.78 million6.08C$1.25 millionC$0.01193.33
Protech Home MedicalC$77.14 million0.62C$833,022.00C$0.0057.50

Hamilton Thorne has higher earnings, but lower revenue than Protech Home Medical. Protech Home Medical is trading at a lower price-to-earnings ratio than Hamilton Thorne, indicating that it is currently the more affordable of the two stocks.

Summary

Hamilton Thorne beats Protech Home Medical on 6 of the 7 factors compared between the two stocks.

Protech Home Medical (CVE:PHM) and Protech Home Medical (CVE:PTQ) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, institutional ownership and profitability.

Earnings & Valuation

This table compares Protech Home Medical and Protech Home Medical's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Protech Home MedicalC$77.14 million0.62C$833,022.00C$0.0057.50
Protech Home MedicalC$82.22 million2.95C$-5,417,568.00C($0.05)-44.79

Protech Home Medical has higher earnings, but lower revenue than Protech Home Medical. Protech Home Medical is trading at a lower price-to-earnings ratio than Protech Home Medical, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Protech Home Medical and Protech Home Medical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Protech Home MedicalN/AN/AN/A
Protech Home MedicalN/AN/AN/A

Analyst Ratings

This is a summary of recent ratings and price targets for Protech Home Medical and Protech Home Medical, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Protech Home Medical0000N/A
Protech Home Medical00503.00

Protech Home Medical has a consensus price target of C$2.58, suggesting a potential upside of 20.16%. Given Protech Home Medical's higher probable upside, analysts plainly believe Protech Home Medical is more favorable than Protech Home Medical.

Summary

Protech Home Medical beats Protech Home Medical on 4 of the 7 factors compared between the two stocks.

Protech Home Medical (CVE:PHM) and Helius Medical Technologies (TSE:HSM) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, earnings, profitability, analyst recommendations, risk and institutional ownership.

Profitability

This table compares Protech Home Medical and Helius Medical Technologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Protech Home MedicalN/AN/AN/A
Helius Medical TechnologiesN/AN/AN/A

Earnings and Valuation

This table compares Protech Home Medical and Helius Medical Technologies' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Protech Home MedicalC$77.14 million0.62C$833,022.00C$0.0057.50
Helius Medical TechnologiesC$661,000.0075.63C$-34,151,124.70C($14.78)-1.46

Protech Home Medical has higher revenue and earnings than Helius Medical Technologies. Helius Medical Technologies is trading at a lower price-to-earnings ratio than Protech Home Medical, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of recent ratings and price targets for Protech Home Medical and Helius Medical Technologies, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Protech Home Medical0000N/A
Helius Medical Technologies0000N/A

Summary

Protech Home Medical beats Helius Medical Technologies on 4 of the 5 factors compared between the two stocks.

Aurora Spine (CVE:ASG) and Protech Home Medical (CVE:PHM) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, analyst recommendations and risk.

Profitability

This table compares Aurora Spine and Protech Home Medical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Aurora SpineN/AN/AN/A
Protech Home MedicalN/AN/AN/A

Valuation and Earnings

This table compares Aurora Spine and Protech Home Medical's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aurora SpineC$8.84 million4.95C$-1,052,790.00C($0.02)-41.58
Protech Home MedicalC$77.14 million0.62C$833,022.00C$0.0057.50

Protech Home Medical has higher revenue and earnings than Aurora Spine. Aurora Spine is trading at a lower price-to-earnings ratio than Protech Home Medical, indicating that it is currently the more affordable of the two stocks.

Dividends

Aurora Spine pays an annual dividend of C$0.11 per share and has a dividend yield of 13.9%. Protech Home Medical pays an annual dividend of C$0.36 per share and has a dividend yield of 313.0%. Aurora Spine pays out -578.9% of its earnings in the form of a dividend. Protech Home Medical pays out 18,000.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Aurora Spine and Protech Home Medical, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Aurora Spine0000N/A
Protech Home Medical0000N/A

Summary

Protech Home Medical beats Aurora Spine on 5 of the 7 factors compared between the two stocks.


Protech Home Medical Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
VMD
Viemed Healthcare
0.3$11.73-0.7%C$464.06 millionC$131.31 million12.02
TMD
Titan Medical
0.8$1.98-6.6%C$216.86 millionC$20 million-4.38Analyst Report
News Coverage
Hamilton Thorne logo
HTL
Hamilton Thorne
1.2$1.74-0.6%C$165.83 millionC$39.78 million193.33
Protech Home Medical logo
PTQ
Protech Home Medical
1.2$2.15-2.8%C$94.56 millionC$82.22 million-44.79
HSM
Helius Medical Technologies
0.5$21.63-0.9%C$49.99 millionC$661,000.00-1.46
ASG
Aurora Spine
0.6$0.79-2.5%C$8.31 millionC$8.84 million-41.58Gap Up
BLO
Cannabix Technologies
0.5N/AN/AC$0.00N/A0.00Gap Up
ORTH
Ortho Regenerative Technologies
0.5N/AN/A$0.00N/A0.00High Trading Volume
Smith & Nephew logo
SNN
Smith & Nephew
0.6N/AN/A$0.00N/A0.00
VMD
Viemed Healthcare
0.5$4.95-2.0%C$0.00N/A0.00Gap Up
This page was last updated on 4/22/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.